26
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      In vivo and in vitro Models of Demyelinating Diseases

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The developmental sequence of a neurotropic strain (JHM) of mouse hepatitis virus was examined by transmission electron microscopy and immunocytology. The nucleo-protein core of this coronavirus, which contains RNA of positive polarity and is helical in configuration, becomes incorporated into enveloped particles in the same manner as the nucleocapsids of the orthomyxo- and paramyxoviruses. However, JHM virus is assembled intracellularly by budding at surfaces of smooth membranous vacuoles. A comparison of JHMvirus replication in L2 and 17C1-1 cell lines revealed that L2 cells undergo more rapid cytopathology and cease virus production much sooner than 17C1-1 cells. In L2 cells the accumulation of core material appears to continue after the abrupt cessation of virus assembly. This is evident by the massive cytoplasmic accumulation of structures resembling nucleocapsids, which react with hybridoma antibody to the nucleocapsid antigen as demonstrated by the immunoperoxidase procedure. The current findings are consistent with our previously published demonstration, using cells of neural and other deviation, of the fundamental role of the host cell type in regulating the replication and expression of coronaviruses.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: found

          Coronaviridae 1

          An informal proposal has been made to group together a number of recently recognized viruses under the head of coronaviruses [1]. They affect a variety of hosts causing a diversity of diseases, but they are grouped together mainly because they have similar electron microscopic appearances, are ether-labile, and probably contain RNA. However, remembering that influenza and parainfluenza viruses were once thought to be quite closely related on similar grounds, much of the grouping should be regarded as tentative. Nevertheless, murine strains (MHV) are antigenically related to some human strains and, morphologically, human, avian, and murine viruses replicate in a similar way; it is therefore likely that at least some of the groupings will be confirmed by further investigation. There is now some more detailed information on the structure of the prototype virus IBV (avian infectious bronchitis virus), the striking features being the large number of peptides and the large single RNA strand. Some strains possess hemagglutinin and there seems to be a hemagglutinin receptor-destroying enzyme which is not a neuraminidase; also there is evidence of a viral RNA polymerase. These features confirm that IBV is quite distinct from other viruses. We still have no detailed information about the biochemical characteristics of its nucleic acid, the process of replication or the lipid composition of the envelope. All in all, the time is now ripe for completing these basic studies of IBV and checking whether the same characteristics are found in the other viruses at present included in the group. It may take years to reach certainty on these points, but we believe this early attempt at taxonomy can be valuable in indicating which facts should be sought first, in order to clarify as soon as possible our understanding of this interesting and superficially diverse group. The Study Group believes that the coronaviruses are sufficiently distinct from other viruses to constitute a family, Coronaviridae; at present, it will have to be considered a monogeneric family. To save space, references included in the review by McIntosh [2] will not be repeated. 1 Taxonomy [2] 1.1 Coronaviridae 1.3 Family with only one genus, Coronavirus 2 The virion 2.1 Chemical composition 2.1.1 Nucleic acid 2.1.1.1 RNA 2.1.1.2 IBV2: single-stranded [5, 6]. HCV: single-stranded [7] 2.1.1.4 Number of pieces: IBV, one [5] 2.1.1.5 Sedimentation coefficients: IBV, 50S [5] 2.1.1.6 Molecular weight: IBV, 9 × 10G [5] 2.1.1.11 Infectivity: Not demonstrated for any member. 2.1.2 Proteins 2.1.2.2 Number of polypeptides: HCV: 6-8 polypeptides [8]: IBV: 16 polypeptides [9] 2.1.2.3 Molecular weight of polypeptides: HCV, 13,000-210,000 [8]. IBV, 14,000-180,000 [9] 2.1.2.5 Enzymes: IBV: possible receptor-destroying enzyme activity [10], possible RNA polymerase [10, 11]. HCV: RNA-dependent RNA polymerase [12]. 2.1.2.6 Other functional proteins: hemagglutinin (HCV: some strains; HEV; IBV: some strains [13]). 2.1.3 Lipids: Present 2.1.4 Carbohydrates: IBV. HCV, TGEV: glycopeptides present. 2.2 Physicochemical properties 2.2.1 Density: 1.16-1.23 g/cm3 in sucrose: 1.23-1.24 g/cm3 in CsCl. 2.2.2 Sedimentation coefficient: HCV: 374-416S, strain OC43: 378-400S, strain 229E [8]. IBV: 330S. 2.2.4 Stability of infectivity 2.2.4.1 pH: TGEV: optimum stability at pH 6.5 [14]. IBV: optimum stability between pH 6.0 and 6.5 [11]. Conflicting or no evidence for other viruses. 2.2.4.2 Heat: Rapidly inactivated at 56°; slow inactivation at 37°; moderately stable at 4°, assuming optimal suspending medium. 2.2.4.5 Other agents: Unstable with common disinfectants and detergents. 2.3 Structure 2.3.1 Nucleocapsid: See 2.3.3. 2 See 10.3 for abbreviations of species. 2.3.2 Envelope: Lipid envelope present, containing peptides and glycopeptides. 2.3.3 Cores: Electron-dense inner shell visible in thin section. HCV: ribonucleoprotein (RNP) core, density 1.31 g/cm3 (CsCl), sedimentation 180S [15]; linear appearance by negative staining [12]. 2.3.3.1 Dimensions: 55-nm diameter in thin section. 2.4 Morphology 2.4.1 Overall shape: Round, non-rigid, some elongated forms. 2.4.2 Dimensions: 60-220 nm 2.4.3 Surface projections: Characteristic bulbous projections, 12-24 nm long, widely spaced. 2.4.4 Special features in thin sections: Inner and outer shells, sometimes separated by electron-lucent space. Some reports of internal threadlike structure. 2.4.5 Other features: Fragile attachment of projections to surface of virion. Inner tongue-shaped membrane sometimes visible by negative staining. 3 Replication 3.1 Site of accumulation of viral proteins: Cytoplasm. 3.2 Nonstructural proteins: Probably present. 3.3 Mode of nucleic acid replication 3.3.2 Effect of inhibitors: Sensitive to 6-azauracil, virazole [10]. Insensitive to 5′-iododeoxyuridine, 5′-bromodeoxyuridine, 5′-fluorodeoxyuridine, cytosine arabinoside, aminopterin and actinomycin D. 3.4 Site and mechanism of maturation: Matures in cytoplasm by budding through endoplasmic reticulum. 3.5 Other features: No budding at plasma membrane. 4 Cooperative interactions: No information available. 5 Host range 5.1 Natural: Generally restricted to normal host species. 5.2 Experimental 5.2.1 In vivo: Generally specific for species of origin: chicken embryos (IBV), suckling mice (MHV, some strains of IBV3 and HCV), newborn rabbits (IBV3). suckling white rats (IBV3), suckling hamsters (HCV), hamsters (MHV). 5.2.2 In vitro: HCV: 1°4 and 2° human embryonic cells, 1° monkey kidney cells, human embryonic tracheal organ cultures. IBV3: 1° 3 Isolation in chicken embryos is essential before adaptation to hosts or cells indicated. 4 1° = First passage. chicken and chicken embryonic cells, 1° monkey kidney, chicken tracheal organ cultures, VERO cells. MHV: L cells, WI-38 cells, 1° mouse and mouse embryonic cells, mouse macrophages, NCTC-1469 cells. TGEV and HEV: 1° porcine cells. TGEV: 1° canine kidney cells. RCV and SDAV: 1° rat kidney cells. 6 Pathogenicity 6.1 Association with diseases: IBV: acute respiratory disease and nephritis in chickens. HCV: common colds in humans. MHV: hepatitis and encephalitis in mice (most strains cause primarily one or the other). TGEV: gastroenteritis in pigs. HEV: encephalitis in pigs. RCV: pulmonary infections of rats. SDAV: sialodacryoadenitis in rats. 6.2 Tissue tropisms: IBV: respiratory and reproductive tract. HCV: upper respiratory tract. TGEV: small intestine, lung. HEV: intestine, brain. MHV: brain, liver, spleen. RCV: lung. SDV: salivary gland. 6.3 Cytopathology: Cellular vacuolation and syncytium formation. 7 Geographic distribution: Probably worldwide. 8 Transmission 8.1 Vertical: HCV: no. IBV: yes. No data available for other strains. 8.2 Horizontal: Yes. 8.3 Vectors 8.3.1 Biological: Not known. 8.3.2 Mechanical: IBV: contaminated equipment, personnel, etc. TGEV: fecal-oral route. HCV: presumed airborne. No data for other strains. 9 Antigenic properties 9.1 Number of distinct antigenic molecules in virion: IBV: up to 3. HCV: 3, possibly 4. MHV: 2. 9.2 Antigens involved in virus neutralization: No adequate information. 9.3 Number of distinct nonstructural antigens: No adequate information. 9.4 Specificity of different antigens: No information. 10 Classification 10.1 Definition of family Coronaviridae: Pleomorphic enveloped particles, averaging 100 nm diameter, containing RNA and essential lipid. Bear unique definitive projections. Multiply in cytoplasm, mature by budding through endoplasmic reticulum. No defined subgroups, but a tentative grouping may be made on basis of serology. IBV, many recognized serotypes, however, all seem to be interrelated, possibly by a common antigen. No interrelationship demonstrated with any of the other coronaviruses. HCV, several serotypes, two main groups-those isolated in tissue culture and those isolated in organ culture. Serologically related to MHV. The three rodent coronaviruses, MHV, RCV and SDAV, are interrelated serologically, and also related to HCV. No adequate information on relationship or diversity between individual strains of MHV. TGEV, no antigenic diversity between strains, possible relationship to HEV. HEV, no antigenic diversity between strains, possible relationship to TGEV. TBDV, only one report available, no relationship shown to other coronaviruses. 10.2 Only one Genus, Coronavirus. Type species: IBV. 10.3 Species: Avian infectious bronchitis virus (IBV) Human Coronavirus (HCV) Murine hepatitis virus (MHV) Porcine transmissible gastroenteritis virus (TGEV) Porcine hemagglutinating encephalitis virus (HEV) Rat Coronavirus (RCV) Sialodacryoadenitis virus of rats (SDAV) Turkey bluecomb disease virus (TBDV) [3] Neonatal calf diarrhea Coronavirus (NCDCV) [4]
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            AN ELECTRON MICROSCOPE STUDY OF THE DEVELOPMENT OF A MOUSE HEPATITIS VIRUS IN TISSUE CULTURE CELLS

            Samples taken at different intervals of time from suspension cultures of the NCTC 1469 line of mouse liver—derived (ML) cells infected with a mouse hepatitis virus have been studied with the electron microscope. The experiments revealed that the viruses are incorporated into the cells by viropexis within 1 hour after being added to the culture. An increasing number of particles are found later inside dense cytoplasmic corpuscles similar to lysosomes. In the cytoplasm of the cells from the samples taken 7 hours after inoculation, two organized structures generally associated and never seen in the controls are observed: one consists of dense material arranged in a reticular disposition (reticular inclusion); the other is formed by small tubules organized in a complex pattern (tubular body). No evidence has been found concerning their origin. Their significance is discussed. With the progression of the infection a system of membrane-bounded tubules and cisternae is differentiated in the cytoplasm of the ML cells. In the lumen of these tubules or cisternae, which are occupied by a dense material, numerous virus particles are observed. The virus particles which originate in association with the limiting membranes of tubules and cisternae are released into their lumen by a "budding" process. The virus particles are 75 mµ in diameter and possess a nucleoid constituted of dense particles or rods limiting an electron transparent core. The virus limiting membrane is sometimes covered by an outer layer of a dense material. In the cells from the samples taken 14 to 20 hours after inoculation, larger zones of the cell cytoplasm are occupied by inclusion bodies formed by channels or cisternae with their lumens containing numerous virus particles. In the samples taken 20 hours or more after the inoculation numerous cells show evident signs of degeneration.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Structure of the ribonucleoprotein of influenza virus.

              The ribonucleoprotein (RNP) internal components of influenza virus were separated into distinct size classes by sedimentation in glycerol gradients and examined by electron microscopy by using positive staining with uranyl acetate. The large RNP have a peak in length distribution at 90 to 110 nm, the medium, at 60 to 90 nm, and the small, at 30 to 50 nm. These lengths can be correlated with the estimated molecular weights of the ribonucleic acids contained in the various RNP size classes. The RNP structure appears to consist of a strand which is folded back on itself and coiled in a regular double-helical arrangement.
                Bookmark

                Author and article information

                Journal
                INT
                Intervirology
                10.1159/issn.0300-5526
                Intervirology
                S. Karger AG
                0300-5526
                1423-0100
                1982
                1982
                24 July 2008
                : 18
                : 3
                : 135-146
                Affiliations
                aCytobiology Group, Department of Microbiology and Immunology, University of Western Ontario, London, Ont., Canada; bDepartment of Immunopathology, Scripps Clinic and Research Foundation, La Jolla, Calif., USA
                Article
                149316 Intervirology 1982;18:135–146
                10.1159/000149316
                6292128
                8639a683-07da-4737-a367-26dd88d0cd7e
                © 1982 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                History
                : 08 December 1981
                Page count
                Pages: 12
                Categories
                Original Paper

                Internal medicine,Respiratory medicine,Clinical Psychology & Psychiatry,Microbiology & Virology,Infectious disease & Microbiology
                Demyelinating diseases,Coronaviruses,Mouse hepatitis virus

                Comments

                Comment on this article